Botanical species · safety record

Dryopteris filix-mas

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Dryopteris filix-mas. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Dryopteris filix-mas (L.) Schott.

5Constituent measurements

1Safety records

5Cited sources

5Licensed products (Canada)

Also recorded as

Polypodium filix-mas L.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Dryopteris filix-mas as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Rhizome
Rhizome(s)
Root

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Aerial part of plants	Solvent extraction	—	UHPLC-MS-MS	Resolve DOI
Phloroglucinol derivatives	Unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Phloroglucinol derivatives	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Saponins	Unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Unspecified	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	—	Roots and other underground parts used as staple food	—	Human (as organism)	Not reported	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Takki, Seppo. Content of some phloroglucinol derivatives in fern extracts. Annales medicinae experimentalis et biologiae fenniae, 1967, vol. 45, no. 3, p. 333-40.
Nardin, Tiziana., Piasentier, Edi., Barnaba, Chiara., Larcher, Roberto. Targeted and untargeted profiling of alkaloids in herbal extracts using online solid-phase extraction and high-resolution mass spectrometry (Q-Orbitrap) . Journal of mass spectrometry, 2016, vol. 51, no. 9, p. 729-741. DOI
Alm Torbjorn. Fern rhizomes as fodder in Norway. Journal of ethnobiology and ethnomedicine, 2016, vol. 12, no. 1, p. 37.
Patil, D. T., Gurav, K. D., Kadam, A. S., Thite, S. V., Thoke, R. B., Kore, B. A. Qualitative analysis of secondary metabolites from some filicales members. International journal of research in pharmacy and chemistry, 2013, vol. 3, no. 2, p. 300-302.
Katekhaye, S. D., Shinde, P. B., Laddha, K. S. Isolation and HPLC method development for filixic acid PBP from Dryopteris filix-mas. International journal of phytopharmacy, 2011, vol. 1, no. 1, p. 1-7.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature